drugset / Trial / NCT00955799

Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

NCT00955799 ↗

Phase 3 Completed 455 enrolled Merz Pharmaceuticals GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.

Timeline

Start
2009-09
Primary completion
2011-05
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Neramexane Small molecule 75 mg —

Indications